NYSE · Health Care · Drug Manufacturers - General
ABBV
AbbVie Inc.
Makes immunology and cancer drugs, and sells Botox and other aesthetic treatments through its Allergan business.
$249.46-0.54%
Close · 2026-08-14$200$220$240$260
NovFebMayAug
$189.40
$267.4752-week range, last close at 77% of the range
- 1W
- +1.39%
- 1M
- +2.19%
- 3M
- +19.41%
- 6M
- +9.43%
- YTD
- +11.76%
- 1Y
- +25.66%
- Avg vol 20d
- 5.3M
- RVOL
- 0.76
- HOLD band
Fundamentalsas of 2026-08-14
- Mkt cap
- $440.83B
- P/E
- 70.5
- Fwd P/E
- 15.3
- EPS
- $3.54
- Div yield
- 2.77%
- Beta
- 0.28
- Employees
- 57K
- Next earnings
- 2026-10-29
Rating & verdict historyoldest → newest
100.0% correct+0.78% avg moveBUY 0/0 · HOLD 1/1 · SELL 0/0
| Date | Call | Outcome | Return | Takeaway |
|---|---|---|---|---|
| 2026-08-14 | Subscribers | — | — | Subscribe to read |
| 2026-08-13 | Subscribers | — | — | Subscribe to read |
| 2026-08-12 | Subscribers | — | — | Subscribe to read |
| 2026-08-11 | Subscribers | — | — | Subscribe to read |
| 2026-08-10 | Subscribers |